GlaxoSmithKline

(NYSE:GSK)

34.10

+0.23 (0.68%)

Dec 04 - Close

Open
34.07
High
34.77
Low
33.80
Vol.
1.69M
Mkt Cap
88.64B
52Wk High
54.64
52Wk Low
31.02
Avg. Vol.
1.89M
P/E (Trailing)
9.19
Beta
0.64
Short %
—
Div. Yield
5.60%

After-Hours 34.09 -0.01 (-0.03%) Thu, 4 Dec 2008 7:40 PM

Company Profile

GlaxoSmithKline

980 Great West Road

Brentford, Middlesex, TW8 9GS

England - Map

Phone: 4402080475000

Fax: 4402080477807

Website: www.gsk.com

CEO: Andrew Witty

Employees: 103,000

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Major

Mks/dist pharmastcls & med equip thru subsidiaries

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products including vaccines, over-the-counter medicines and health-related consumer products.

Recent news for GSK

Recent opinions on GSK

No recent Opinions for GSK

Top members owning GSK

Members owning GSK also own

PFE (33.33%), PG (22.22%), MSFT (22.22%), GE (22.22%), V (22.22%)

Member sentiment: Neutral